0
0
MUMBAI — In a major move to protect vulnerable patients and curb medical malpractice, the Maharashtra government announced on Wednesday the formation of a Special Task Force (STF) dedicated to inspecting and regulating in-vitro fertilization (IVF) and sonography centres across the state. Public Health Minister Prakash Abitkar informed the state assembly that the government is also considering a strict new legal framework that could classify repeat or severe violations under organized crime laws, with a draft bill expected as early as the next legislative session.
The announcement follows rising concerns voiced by lawmakers and health advocates regarding the rapid proliferation of unregulated fertility clinics and diagnostic facilities. Triggered by a formal inquiry from Samajwadi Party MLA Abu Azmi, the state-wide enforcement drive aims to root out unauthorized operators, prevent financial exploitation, and ensure strict compliance with federal reproductive health laws.
Escalating Enforcement and the Shadows of Organised Crime
According to health ministry officials, the newly established STF will possess broad powers to conduct unannounced inspections, audit medical records, and immediately seal facilities operating without proper registration. The crackdown represents a significant escalation in the state’s oversight of reproductive medicine.
“We are taking a zero-tolerance approach to facilities that exploit the hopes of families,” Minister Abitkar stated during the assembly session. He noted that treating severe violations as organized crime would grant law enforcement agencies stronger tools to dismantle networks involved in illegal egg extraction, fraudulent fertility promises, and unauthorized diagnostic services.
The state’s intensified focus comes on the heels of several high-profile investigations earlier this year involving illegal oocyte (egg) harvesting rings and fertility-related fraud. Local authorities have already audited thousands of facilities in recent months, issuing notices and launching criminal investigations into centers suspected of violating statutory norms.
Why Reproductive Health Care Demands Strict Regulation
The expansion of unregulated clinics poses severe risks to public health. IVF—a medically assisted reproduction treatment where an egg is fertilized by sperm outside the body—requires meticulous clinical oversight. According to the World Health Organization (WHO), infertility affects approximately one in six people of reproductive age worldwide. Because fertility treatments are emotionally exhausting, time-sensitive, and financially demanding, patients are highly vulnerable to misleading advertisements, hidden costs, and substandard procedures that can jeopardize their health or the viability of embryos.
GLOBAL INFERTILITY PREVALENCE (WHO)
[█ ] 1 in 6 people worldwide experience infertility
Simultaneously, sonography (ultrasound) centers are bound by stringent statutory frameworks in India. Under the Pre-Conception and Pre-Natal Diagnostic Techniques (PC & PNDT) Act of 1994, using ultrasound technology for fetal sex determination is strictly prohibited to prevent female foeticide and correct skewed sex ratios. The law mandates strict registration, exhaustive record-keeping of every pregnancy scan, and routine compliance checks.
Public health experts emphasize that unauthorized sonography centers frequently operate off-the-grid, bypassing these documentation rules to cater to illegal sex-selection networks.
Balancing Accountability with Patient Access
While independent medical professionals welcome the government’s intervention, they caution that the crackdown must be executed with precision.
“Oversight is absolutely critical to protect patients from predatory practices, but we must ensure that legitimate, law-abiding clinics are not subjected to bureaucratic harassment,” said Dr. Anita Deshmukh, a Mumbai-based reproductive endocrinologist not involved in the government’s task force. “Overly aggressive or generalized crackdowns can cause panic, potentially disrupting ongoing treatments for couples who are already undergoing legitimate, highly time-sensitive IVF cycles.”
The WHO underscores that effective fertility care relies on a combination of trained personnel, adequate infrastructure, and transparent quality monitoring, rather than enforcement alone. Public health advocates argue that if monitoring remains uneven or if affordable, authorized care is unavailable, patients may continue to seek out cheaper, unregulated alternatives.
What Patients and Consumers Should Do
In light of the state’s ongoing enforcement actions, medical authorities urge health-conscious consumers and patients navigating infertility to protect themselves by exercising due diligence before choosing a provider.
Red Flags and Safety Checklist for Patients:
Verify Registration: Ensure the facility prominently displays its official registration certificates under both the Clinical Establishments Act and the PC & PNDT Act.
Demand Written Plans: Legitimate clinics provide clear, itemized treatment pathways and transparent breakdown of costs before any procedure begins.
Beware of Guarantees: Avoid clinics that guarantee 100% success rates or offer “packages” that promise specific outcomes, as clinical success depends heavily on individual medical factors.
Avoid Gender Hints: Any clinic offering hints, codes, or assurances regarding the sex of the fetus is operating illegally under Indian law.
Medical professionals remind the public that infertility is a common, treatable medical condition with diverse physiological causes, not a personal or social failure. Safe care always begins with an accurate diagnosis from qualified obstetricians, gynecologists, radiologists, or certified fertility specialists working out of authorized, transparent institutions.
References
- https://health.economictimes.indiatimes.com/news/policy/maharashtra-govt-to-form-task-force-against-illegal-ivf-and-sonography-centres-minister-in-assembly/132112325?utm_source=latest_news&utm_medium=homepage
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
